Filter
1479
Filtered Results: 1479
Text search:
World
Health
Organization
(Regional
Office
for
South-East-Asia)
Featured
Recommendations
137
New Publications
388
Language
Document type
No document type
763
Studies & Reports
345
Guidelines
178
Manuals
76
Strategic & Response Plan
55
Training Material
16
Situation Updates
15
Fact sheets
13
Resource Platforms
9
Infographics
5
Brochures
2
Online Courses
2
Countries / Regions
Global
97
South–East Asia Region
67
India
58
Myanmar / Burma
57
Nepal
44
Asia
42
Philippines
29
Bangladesh
26
Western and Central Europe
25
Indonesia
22
Africa
21
Cambodia
16
Ethiopia
14
Uganda
14
Western Pacific Region
14
Kenya
12
Thailand
12
Syria
11
Pakistan
10
Middle East and North Africa
10
Liberia
9
Afghanistan
9
Eastern Europe
9
Tanzania
8
South Africa
8
Zambia
7
Ukraine
7
Haiti
6
Mozambique
6
Sri Lanka
6
Yemen
6
Laos
6
Sierra Leone
5
Nigeria
5
Congo, Democratic Republic of
5
Ghana
5
Somalia
5
China
5
Rwanda
5
Malawi
5
East and Southern Africa
5
West and Central Africa
5
Latin America and the Carribbean
5
Russia
5
Zimbabwe
4
South Sudan
4
Sudan
4
Venezuela
4
Moldova
4
Vietnam
4
Burkina Faso
3
Senegal
3
Jordan
3
Papua New Guinea
3
Central African Republic
3
North Macedonia
3
Eastern Europe and Central Asia
3
Timor Leste/ East Timor
3
Iran
3
Georgia
3
Guinea
2
USA
2
Iraq
2
Lebanon
2
Turkey
2
Malaysia
2
Eswatini/ Swaziland
2
Madagascar
2
Mexico
2
North Korea
2
Albania
2
Kazakhstan
2
Belarus
2
Bosnia and Herzegovina
2
Morocco
1
Saudi Arabia
1
Cameroon
1
Egypt
1
Singapore
1
Vanuatu
1
Argentina
1
Peru
1
Brazil
1
Hungary
1
Croatia
1
Ecuador
1
Greece
1
Lesotho
1
Other region
1
Paraguay
1
Solomon Islands
1
Bhutan
1
Poland
1
Palestine
1
Djibouti
1
Armenia
1
Mongolia
1
Tajikistan
1
Qatar
1
Romania
1
Kyrgyzstan
1
Gabon
1
Turkmenistan
1
Japan
1
Belgium
1
Maldives
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
358
Clinical Guidelines
161
Public Health
106
Women & Child Health
98
Key Resources
82
Capacity Building
26
Pharmacy & Technologies
18
Toolboxes
HIV
157
Mental Health
127
COVID-19
105
Planetary Health
97
TB
69
Rapid Response
60
NTDs
59
AMR
57
Global Health Education
50
Disability
49
Refugee
39
Caregiver
34
Natural Hazards
31
NCDs
27
Health Financing Toolbox
24
Conflict
23
Pharmacy
20
Zika
16
Ebola
11
Cholera
7
Specific Hazards
7
Polio
6
Typhoon
3
Social Ethics
1
Health Financing
1
Recommendations for a Public Health approach and considerations for policy-makers and managers
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and ... the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vaccines in priority disease areas. PPCs are intended to encourage innovation and development of vaccines for use in settings most relevant to the global unmet public health need.
Gonococcal vaccine PPCs describe global public health goals for gonococcal vaccines and preferred parameters pertaining to vaccine indications and target populations, safety and efficacy considerations, and immunization strategies.
This publication is based on the list of clinical interventions selected from clinical guidelines on prevention, screening, diagnosis, treatment, palliative care, monitoring and end of life care. This publication addresses medical devices for six ty...
Validation of elimination of mother-to-child transmission, or vertical transmission, of HIV, syphilis and hepatitis B virus (HBV), is an attestation that a country has successfully met standard criteria for elimination, or ... being at 1 of the 3 levels of achievement on the ‘Path to Elimination’ while delivering quality services for women, girls and their children, through the life-course, respecting human rights and ensuring gender equality and community engagement.
This document, the third version, adds on EMTCT of hepatitis B virus (HBV), bringing together a package of interventions and metrics to support integrated management and monitoring of vertical transmission across a wide range of epidemiological and programmatic contexts.
This document, the third version, adds on EMTCT of hepatitis B virus (HBV), bringing together a package of interventions and metrics to support integrated management and monitoring of vertical transmission across a wide range of epidemiological and programmatic contexts.
This update of the Guidelines for poison control, entitled Guidelines for establishing a poison centre, reflects the development of the role of poison centres in public ... and the sound management of chemicals, described in section 1, and the opportunities provided by new technology. Assessments carried out under the IHR show
continuing gaps in capacity for managing chemicals (2). In particular, many countries still lack access to poison
centre services (3). There is therefore demand for updated guidance.
WHO Recommendations 2018 Update
The primary audience for these recommendations includes health professionals who are responsible for developing na...
Health Evidence Network synthesis report 53
Guidelines for malaria vector control
recommended
these guidelines are updated on 16 February 2021
Please check the new guideline here
https://medbox.org/document/who-guidelines-for-malaria#GO
Nepal has only recently started its journey on the path to an integrated response to the challenge of antimicrobial resistance (AMR). Despite this, it is notable that the Nepal Health Sector Strategy Plan (HSSP)-2 mentions growing antibiotic resista...
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providin...
These guidelines deal specifically with water, sanitation and hygiene, and are designed to be used in schools in low-cost settings in low- and medium-resource countries to:
• assess prevailing situations and plan for required improvements;
• ...
The Guidance on global monitoring for diabetes prevention and control by WHO provides a comprehensive framework to support countries in tracking and managing diabetes prevention, care, and outcomes. This document outlines indicators across 4 domains...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti...
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal ... Coverage/Communicable and Noncommunicable Diseases, welcomed participants to the meeting. He said the World Health Organization’s Department of Control of Neglected Tropical Diseases (WHO/NTD) was in a state of transition. Following the death of the late esteemed Director Dr Mwelecele Ntuli Malecela earlier in the year, Dr Gautam Biswas had taken over as Acting Director but would soon retire; the appointment of a new Director was under way. Owing to rotation of STAG-NTD members, this would be the last meeting for some and the first meeting for several new participants. The work however would continue with the same commitment. Discussions over the next two days would focus on critical issues regarding recovery of NTD services following the disruptions caused by coronavirus disease (COVID-19), which had impacted many health services worldwide. He looked forward to receiving the advice and guidance of STAG-N
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
recommended
The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those wi...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
